CD40 on NOD CD4 T cells contributes to their activation and pathogenicity

被引:49
作者
Baker, Rocky L. [1 ,2 ]
Wagner, David H., Jr. [3 ,4 ]
Haskins, Kathryn [1 ,2 ]
机构
[1] Univ Colorado, Dept Immunol, Denver, CO 80206 USA
[2] Natl Jewish Hlth, Denver, CO 80206 USA
[3] Univ Colorado, Webb Waring Inst, Denver, CO 80206 USA
[4] Univ Colorado, Dept Med, Denver, CO 80206 USA
关键词
CD40; NOD; Type; 1; diabetes; CD4 T cells;
D O I
10.1016/j.jaut.2008.09.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Our goals in this study were to investigate conditions under which T cells from NOD mice express CD40 and to determine how CD40 on autoreactive CD4 T cells contributes to their pathogenicity in T1D. Using CD40-positive diabetogenic T cell clones and CD4 T cells from NOD mice, we examined expression of CD40 upon activation through the TCR and costimulation through either CD28 or CD40. Our results indicate that CD40 expression is increased upon activation with antigen/MHC and that activation of NOD CD4 T cells through TCR/CD40 rapidly induced CD40 expression. Furthermore, CD40 costimulation promoted T cell proliferation to the same extent as costimulation through TCR/CD28. Importantly, costimulation of CD4 T cells through CD40 also interfered with T cell homeostasis by altering regulation of CTLA-4 expression. Through CD40-CD154 blocking studies, we demonstrated that signaling between T cells through CD40 and its ligand contributes to activation of pathogenic T cells and that blocking CD40 on T cells abrogates their ability to transfer diabetes. Thus, costimulation through CD40 on NOD T cells contributes to their pathogenicity by providing additional pathways for activation and by inhibiting upregulation of CTLA-4 during T cell activation. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:385 / 392
页数:8
相关论文
共 33 条
[1]   CD154-dependent priming of diabetogenic CD4+ T cells dissociated from activation of antigen-presenting cells [J].
Amrani, A ;
Serra, P ;
Yamanouchi, J ;
Han, BY ;
Thiessen, S ;
Verdaguer, J ;
Santamaria, P .
IMMUNITY, 2002, 16 (05) :719-732
[2]   Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism [J].
Arreaza, GA ;
Cameron, MJ ;
Jaramillo, A ;
Gill, BM ;
Hardy, D ;
Laupland, KB ;
Rapoport, MJ ;
Zucker, P ;
Chakrabarti, S ;
Chensue, SW ;
Qin, HY ;
Singh, B ;
Delovitch, TL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2243-2253
[3]  
Balasa B, 1997, J IMMUNOL, V159, P4620
[4]   ISLET-SPECIFIC T-CELL CLONES FROM THE NOD MOUSE RESPOND TO BETA-GRANULE ANTIGEN [J].
BERGMAN, B ;
HASKINS, K .
DIABETES, 1994, 43 (02) :197-203
[5]   CD40: CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes [J].
Bhushan, A ;
Covey, LR .
IMMUNOLOGIC RESEARCH, 2001, 24 (03) :311-324
[6]  
Bishop GA, 2007, ADV EXP MED BIOL, V597, P131
[7]   CD28 function: A balance of costimulatory and regulatory signals [J].
Bour-Jordan, H ;
Bluestone, JA .
JOURNAL OF CLINICAL IMMUNOLOGY, 2002, 22 (01) :1-7
[8]   A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory [J].
Bourgeois, C ;
Rocha, B ;
Tanchot, C .
SCIENCE, 2002, 297 (5589) :2060-2063
[9]   Effector function of diabetogenic CD4 Th1 T cell clones:: A central role for TNF-α [J].
Cantor, J ;
Haskins, K .
JOURNAL OF IMMUNOLOGY, 2005, 175 (11) :7738-7745
[10]   Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation [J].
Dahlén, E ;
Hedlund, G ;
Dawe, K .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2444-2456